In an intermediate clinical trial, the highest dose of Eli Lilly's experimental orforglipron $LLY pill led to a 14.7% weight loss in obese or overweight people after 36 weeks, setting a new milestone in the race to develop effective anti-obesity pills.
On the one hand, great, but on the other hand, I'm thinking it's not so fabulous when you can achieve those percentages with exercise and diet in the same amount of time. Nevertheless, the Yanks will appreciate it and the numbers will gradually improve.
Do you think there is potential in this area? Not in healthcare directly, but in obesity pills.